Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
RainDance Technologies says its method of amplifying DNA in drops of water will expand clinical genetic testing.
New research suggests that most people can cope with learning that they are at high genetic risk for disease.
By validating an emerging technology, two new genomic studies offer hope for the fight against disease.
Ten volunteers may reveal their genetic and medical data.
The founders of startup 23andMe want to know your genome.
The data will be compared against electronic health records and patients’ personal information.
The number of genetic tests that can be performed during in vitro fertilization is skyrocketing. What does this mean for human reproduction?
Mapping the genome of a fetus from its mother’s blood could mean less risky screening for prenatal diseases.